Darunavir Vorapaxar 965

Prezista label

Clinical Bottom Line
Minimal data to guide interaction: risks likely to outweigh benefits
Drug 1
Drug 2
Clinical Effects

Potential for increased bleeding risk

Management

Avoid combination and use alternative antiplatelet agent

Import ID
965